D J Horsfall
Overview
Explore the profile of D J Horsfall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hall R, Horsfall D, Stahl J, Vivekanandan S, Ricciardelli C, Stapleton A, et al.
Prostate
. 2004 Jan;
58(2):103-8.
PMID: 14716735
Background: High grade prostatic intraepithelial neoplasia (HGPIN) is a putative pre-malignant lesion of the prostate. While apolipoprotein-D (Apo-D), an androgen-regulated hydrophobic transporter protein, is expressed in prostate tumors, its expression...
2.
Sakko A, Ricciardelli C, Mayne K, Tilley W, LeBaron R, Horsfall D
Cancer Res
. 2001 Feb;
61(3):926-30.
PMID: 11221884
We have previously demonstrated that peritumoral stromal matrix derived from prostate cancer patients who relapse after radical surgery contains elevated levels of versican. The purpose of this study was to...
3.
Buchanan G, Yang M, Harris J, Nahm H, Han G, Moore N, et al.
Mol Endocrinol
. 2001 Jan;
15(1):46-56.
PMID: 11145738
The androgen receptor (AR), a member of the steroid receptor superfamily of nuclear transcription factors, mediates androgen signaling in diverse target tissues. Here we report AR gene mutations identified in...
4.
Bentel J, Birrell S, Pickering M, Holds D, Horsfall D, Tilley W
Mol Cell Endocrinol
. 1999 Oct;
154(1-2):11-20.
PMID: 10509795
Medroxyprogesterone acetate (MPA), which is frequently used as second line hormonal therapy for the treatment of metastatic breast cancer, binds with high affinity to the progesterone receptor (PR). However, the...
5.
Lockwood C, Ricciardelli C, Raymond W, Seshadri R, McCaul K, Horsfall D
Int J Cancer
. 1999 Jun;
84(3):203-8.
PMID: 10371334
Image analysis was used to investigate the prognostic significance of immunostaining for oestrogen receptor (ER), p53 tumour-suppressor protein and tumour cell proliferation (MIB-1) in a random cohort of 200 primary...
6.
Ricciardelli C, Quinn D, Raymond W, McCaul K, Sutherland P, Stricker P, et al.
Cancer Res
. 1999 May;
59(10):2324-8.
PMID: 10344737
The disease course of localized prostate cancer is highly variable, and patients potentially curable by aggressive management are not readily identified by current clinical practice. Chondroitin sulfate (CS) glycosaminoglycan is...
7.
Zhang S, Bentel J, Ricciardelli C, Horsfall D, Haagensen D, Marshall V, et al.
J Urol
. 1998 Jul;
159(2):548-54.
PMID: 9649289
Purpose: To determine the cellular distribution and levels of immunohistochemical staining for apolipoprotein D (Apo-D), prostate specific antigen (PSA) and androgen receptor (AR) in early stage prostate cancers. Materials And...
8.
MAYERS M, Seshadri R, Raymond W, McCaul K, Horsfall D
Pathology
. 1998 Jun;
30(2):105-10.
PMID: 9643487
There is a continuing controversy regarding the value of estimating degree of intra-tumor vascularity to predict prognosis in breast cancer. In order to resolve this controversy, primary tumors from a...
9.
Ricciardelli C, Mayne K, Sykes P, Raymond W, McCaul K, Marshall V, et al.
Clin Cancer Res
. 1998 May;
4(4):963-71.
PMID: 9563891
Patients with clinically localized prostate cancer who might be cured by aggressive management are not easily identified using current clinical information. Additional, more accurate, biomarkers of tumor behavior need to...
10.
Seshadri R, Horsfall D, McCaul K, Leong A
Aust N Z J Surg
. 1997 Dec;
67(11):765-70.
PMID: 9396991
Background: Since the course of breast cancer is often unpredictable, we wished to develop a model using characteristics of the primary tumour alone to predict prognosis. Methods: Several tumour features...